High ferritin levels, abnormal PET/CT CNS metabolism, and peripheral immunophenotype (PD-1+, TEM, CD57+, and CD73+) are some highlights that could help to recognize DM patients who are prone to developing encephalopathy symptoms. This evidence concerns the gene B3GAT1 and dermatomyositis.